Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
US9296692B2 · kind B2 · utility
1Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2012 |
| Grant date | Mar 29, 2016 |
| Priority date | — |
| Expiry date | Oct 28, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel use of small molecules, particularly indolyl and indolinyl hydroxamates is disclosed herein. The indolyl and indolinyl hydroxamates are useful as lead compounds for manufacturing a medicament or a pharmaceutical composition for treating a patient suffering from heart failure or neuronal injury.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.